Getting the right diagnosis is the first step toward understanding retinitis pigmentosa and managing your vision. The diagnostic journey typically begins with recognizing symptoms and involves several specialized eye examinations that help doctors confirm the condition, understand its progression, and distinguish it from other eye problems.

Introduction: Who Should Seek Diagnostic Testing

Retinitis pigmentosa is a condition you are born with, though symptoms usually do not appear immediately. If you notice difficulty seeing in dark or dimly lit places, especially if this trouble begins in childhood or teenage years, it is important to see an eye care professional. Parents may observe that their children struggle to move around in the dark or have trouble adjusting when going from bright rooms to darker ones.^[1]

Another important early sign is losing your side vision, which doctors call peripheral vision. This means you may have trouble noticing things out of the corners of your eyes. Over time, your field of vision can narrow, creating what is known as tunnel vision, where you only see clearly in a small area directly in front of you.^[2]

Because retinitis pigmentosa is a genetic condition passed down through families, anyone with a family history of the disease should consider getting tested, even if they do not yet have symptoms. Early diagnosis can help you and your family understand what to expect and plan for the future. While symptoms may be subtle at first and progress slowly, some people do not recognize the problem until much later in life. However, getting evaluated early allows you to access support services, learn coping strategies, and stay informed about emerging treatments.^[2]

Diagnostic Methods for Identifying Retinitis Pigmentosa

Diagnosing retinitis pigmentosa involves several specialized eye tests that work together to paint a complete picture of your retinal health. The process typically starts with a comprehensive dilated eye exam, which is simple and painless. Your eye doctor will place special drops in your eyes to widen your pupils, allowing a clear view of the retina at the back of your eye. During this examination, the doctor can look for characteristic signs of RP and other eye problems.^[1]

An essential part of the dilated eye exam includes a visual field test, which checks your peripheral vision. This test measures how much you can see to the sides while looking straight ahead. Since loss of side vision is a hallmark of retinitis pigmentosa, this test provides crucial information about how the disease is affecting your eyes.^[1]

Electroretinography (ERG)

One of the most important diagnostic tools for retinitis pigmentosa is electroretinography, or ERG. This test lets your eye doctor check how well your retina responds to light. The retina contains two types of special cells called photoreceptors: rods and cones. Rods help you see in low light and provide peripheral vision, while cones detect colors and fine details in bright light. In RP, these photoreceptor cells gradually stop working, and the ERG can measure this decline.^[1]

During an ERG test, the doctor measures the electrical signals your retina produces when exposed to light. Because RP usually affects rod cells first and cone cells later, the ERG can show which type of cells are damaged and how severe the damage is. This information helps doctors understand what stage of the disease you are experiencing.^[2]

Optical Coherence Tomography (OCT)

Another valuable test is optical coherence tomography, or OCT. This test uses light waves to create a detailed, cross-sectional picture of your retina. The images show the different layers of retinal tissue and can reveal thinning or damage caused by RP. The OCT is painless and quick, providing doctors with precise information about the structure of your retina.^[1]

Fundus Autofluorescence (FAF) Imaging

Fundus autofluorescence imaging is another specialized test your doctor may use. In this examination, the eye doctor uses blue light to take pictures of your retina. When photoreceptor cells break down, they leave behind a buildup of pigment on the retina. The name “retinitis pigmentosa” actually refers to this pigment buildup, although the term is somewhat misleading since the condition does not cause inflammation, which “retinitis” would suggest. FAF imaging can detect these changes and help track disease progression.^[1][2]

Genetic Testing

Your doctor may also recommend genetic testing to learn more about the specific type of retinitis pigmentosa you have. Researchers have identified close to 100 different gene variations that can cause RP. Understanding which genetic mutation is responsible for your condition can tell you how your symptoms may change over time and help determine your risk of passing RP to your children.^[1][4]

Genetic testing typically involves a blood sample or sometimes a saliva sample. The results can take several weeks to return. While genetic testing is not required for diagnosis, it provides valuable information that can guide your healthcare decisions and family planning. You may also want to speak with a specialist called a genetic counselor, who can help you understand your test results and what they mean for you and your family.^[1]

Additional Diagnostic Tests

During your diagnostic evaluation, your eye doctor will also perform standard vision tests. These include checking your visual acuity, which measures how clearly you see at various distances, and testing your color vision, since RP can eventually affect your ability to detect different colors. The doctor will also examine your eyes for other signs of RP, such as sensitivity to bright light.^[2]

Many eye care professionals recommend annual examinations for people with retinitis pigmentosa, including visual field testing. Some doctors suggest repeating the ERG evaluation every five years. These regular check-ups help track how the disease is progressing and can provide reassurance when changes are happening slowly. Regular monitoring also ensures you have appropriate support from community services and keeps you informed about new treatments and clinical trials as they become available.^[8]

Diagnostics for Clinical Trial Qualification

If you are interested in participating in clinical trials for retinitis pigmentosa, you will need to undergo specific diagnostic tests that researchers use as standard criteria for enrolling patients. These tests help ensure that participants meet the requirements for the study and establish baseline measurements that researchers will use to evaluate whether experimental treatments are working.

Clinical trials typically require a comprehensive eye examination that includes many of the same tests used in standard diagnosis. Visual acuity testing measures how well you can read letters on an eye chart. This measurement is critical because many trials track whether vision improves, stabilizes, or continues to decline during the study period.^[7]

Visual field testing is another standard requirement for clinical trial enrollment. This test measures the extent of your remaining vision, both centrally and peripherally. Some trials specifically look for patients who still have a certain amount of vision remaining, as treatments may be more effective when started before too much vision is lost. Researchers often use these measurements as primary outcomes to determine if a treatment is successful.^[7]

Electroretinography is commonly required for trial qualification because it provides objective data about photoreceptor function. Some trials focus on participants whose ERG shows a specific pattern of rod or cone cell damage. Other studies may use specialized versions of the ERG test, such as low luminance visual acuity (LLVA), which measures your ability to read letters on an eye chart in dim light. Recent clinical trials have used LLVA as a key measurement to evaluate treatment effectiveness.^[7]

Optical coherence tomography scans are frequently used in clinical trials to measure the thickness of different retinal layers and to monitor changes over time. These detailed images allow researchers to see whether experimental treatments are slowing the loss of photoreceptor cells or preserving retinal structure.^[6]

Genetic testing is especially important for trials targeting specific genetic forms of retinitis pigmentosa. For example, some studies only enroll patients with mutations in particular genes, such as RPE65, RPGR, or USH2A. You must provide documentation of your genetic test results showing that you have the specific mutation the trial is studying. This requirement ensures that researchers are testing treatments on the appropriate patient population.^[7]

Some advanced trials may also use microperimetry, a test that measures light sensitivity at multiple points across your retina. This provides a detailed map of which areas of your retina are still functioning well and which have lost sensitivity. Improvements in microperimetry scores can indicate that a treatment is helping preserve or restore retinal function.^[7]

Blood tests may also be required for some clinical trials, not to diagnose RP itself, but to ensure that participants are healthy enough to receive experimental treatments safely. Additionally, if you are considering trials involving stem cell therapies, researchers may need to collect and test cells from your bone marrow to confirm they can be successfully isolated and prepared for treatment.^[10]

The diagnostic requirements for clinical trials are more extensive than routine clinical care because researchers need precise, standardized measurements to evaluate whether treatments work. While the process may seem demanding, these thorough evaluations help advance scientific understanding and bring new therapies closer to reality for everyone affected by retinitis pigmentosa.